Skip to content
Screener

EPS (Diluted) at other companies

Intel logo
IntelINTC
-$2.16-222%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.27-0.9%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$0.14-88.4%
Mobileye Global Inc. logo
Mobileye Global Inc.MBLY
-$0.03+62.5%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
-$0.05+54.5%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-$0.34+19.0%

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%

Balance sheet

See full
Cash & equivalents$30.5M-19.6%
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$119.08M+126%
P/S121.5×+64.1×

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Reported directly by Rafael Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026.

Filed
Jun 11, 2026, 8:17 AM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001213900-26-067560
Line itemThree Months Ended April 30, 2026Three Months Ended April 30, 2025Nine Months Ended April 30, 2026Nine Months Ended April 30, 2025
Foreign currency translation adjustment24411037
Comprehensive loss(2,608)(3,963)(18,646)(18,444)
Comprehensive income (loss) attributable to noncontrolling interests1,3277281,432(165)
Comprehensive loss attributable to Rafael Holdings, Inc.$(3,935)$(4,691)$(20,078)$(18,279)
Loss per share attributable to common stockholders
Basic and diluted$(0.08)$(0.19)$(0.40)$(0.73)
Weighted average number of shares used in calculation of loss per share
Basic and diluted51,229,57625,238,50151,327,94325,131,655

Cover / Front Matter

FAQ

What is Rafael Holdings, Inc.'s EPS (diluted)?
Rafael Holdings, Inc. (RFL) reported EPS (diluted) of -$0.08 in Q1 2026.
How has Rafael Holdings, Inc.'s EPS (diluted) changed year-over-year?
Rafael Holdings, Inc.'s EPS (diluted) increased by 57.9% year-over-year, from -$0.19 to -$0.08.
What is the long-term trend for Rafael Holdings, Inc.'s EPS (diluted)?
Over 3 years (2021 to 2025), Rafael Holdings, Inc.'s EPS (diluted) has grown at a -10.5% compound annual growth rate (CAGR), from -$1.48 to -$1.06.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Rafael Holdings, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude